These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 28211055)

  • 1. Pemphigus, a pathomechanism of acantholysis.
    Furue M; Kadono T
    Australas J Dermatol; 2017 Aug; 58(3):171-173. PubMed ID: 28211055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pemphigus: a complex T cell-dependent autoimmune disorder leading to acantholysis.
    Veldman C; Feliciani C
    Clin Rev Allergy Immunol; 2008 Jun; 34(3):313-20. PubMed ID: 18097775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-pathogenic pemphigus foliaceus (PF) IgG acts synergistically with a directly pathogenic PF IgG to increase blistering by p38MAPK-dependent desmoglein 1 clustering.
    Yoshida K; Ishii K; Shimizu A; Yokouchi M; Amagai M; Shiraishi K; Shirakata Y; Stanley JR; Ishiko A
    J Dermatol Sci; 2017 Mar; 85(3):197-207. PubMed ID: 28024684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biphasic activation of p38MAPK suggests that apoptosis is a downstream event in pemphigus acantholysis.
    Lee HE; Berkowitz P; Jolly PS; Diaz LA; Chua MP; Rubenstein DS
    J Biol Chem; 2009 May; 284(18):12524-32. PubMed ID: 19270308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desmoglein versus non-desmoglein signaling in pemphigus acantholysis: characterization of novel signaling pathways downstream of pemphigus vulgaris antigens.
    Chernyavsky AI; Arredondo J; Kitajima Y; Sato-Nagai M; Grando SA
    J Biol Chem; 2007 May; 282(18):13804-12. PubMed ID: 17344213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pemphigus vulgaris: recent advances in our understanding of its pathogenesis.
    Femiano F
    Minerva Stomatol; 2007 Apr; 56(4):215-23. PubMed ID: 17452959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergy among non-desmoglein antibodies contributes to the immunopathology of desmoglein antibody-negative pemphigus vulgaris.
    Chernyavsky A; Amber KT; Agnoletti AF; Wang C; Grando SA
    J Biol Chem; 2019 Mar; 294(12):4520-4528. PubMed ID: 30692201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice.
    Amagai M; Nishikawa T; Nousari HC; Anhalt GJ; Hashimoto T
    J Clin Invest; 1998 Aug; 102(4):775-82. PubMed ID: 9710446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies against desmoglein 2 are not pathogenic in pemphigus.
    Miguel MCB; Julio TA; Vernal S; de Paula NA; Lieber A; Roselino AM
    An Bras Dermatol; 2022; 97(2):145-156. PubMed ID: 35058080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions.
    Nguyen VT; Ndoye A; Shultz LD; Pittelkow MR; Grando SA
    J Clin Invest; 2000 Dec; 106(12):1467-79. PubMed ID: 11120754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the pathogenicity of anti-desmoglein antibodies of pemphigus vulgaris patients using human organ culture assay.
    Saleh AM; El-Samanoudy SI; Rashed LA; Saleh MA
    Arch Dermatol Res; 2020 May; 312(4):289-294. PubMed ID: 31587106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-desmoglein 1 autoantibodies in pemphigus vulgaris sera are pathogenic.
    Ding X; Diaz LA; Fairley JA; Giudice GJ; Liu Z
    J Invest Dermatol; 1999 May; 112(5):739-43. PubMed ID: 10233765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro pathogenicity assay for anti-desmoglein autoantibodies in pemphigus.
    Ishii K; Amagai M
    Methods Mol Biol; 2013; 961():219-25. PubMed ID: 23325646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in desmoglein 1 expression and subcellular localization in cultured keratinocytes subjected to anti-desmoglein 1 pemphigus autoimmunity.
    Cirillo N; Gombos F; Lanza A
    J Cell Physiol; 2007 Feb; 210(2):411-6. PubMed ID: 17058228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pemphigus IgG causes skin splitting in the presence of both desmoglein 1 and desmoglein 3.
    Spindler V; Drenckhahn D; Zillikens D; Waschke J
    Am J Pathol; 2007 Sep; 171(3):906-16. PubMed ID: 17640963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of synergy of autoantibodies to M3 muscarinic acetylcholine receptor and secretory pathway Ca
    Chernyavsky A; Patel KG; Grando SA
    Int Immunopharmacol; 2020 Mar; 80():106149. PubMed ID: 31958740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide-mediated desmoglein 3 crosslinking prevents pemphigus vulgaris autoantibody-induced skin blistering.
    Spindler V; Rötzer V; Dehner C; Kempf B; Gliem M; Radeva M; Hartlieb E; Harms GS; Schmidt E; Waschke J
    J Clin Invest; 2013 Feb; 123(2):800-11. PubMed ID: 23298835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gluteal hidradenitis suppurativa presenting pemphigus-like findings: case report.
    Kurihara Y; Furue M
    BMC Dermatol; 2019 Jul; 19(1):11. PubMed ID: 31337387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgG autoantibodies directed against desmoglein 3 cause dissociation of keratinocytes in canine pemphigus vulgaris and paraneoplastic pemphigus.
    Nishifuji K; Olivry T; Ishii K; Iwasaki T; Amagai M
    Vet Immunol Immunopathol; 2007 Jun; 117(3-4):209-21. PubMed ID: 17350107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of intravenous immunoglobulin (IVIG) affinity-purified anti-desmoglein anti-idiotypic antibodies in the treatment of an experimental model of pemphigus vulgaris.
    Mimouni D; Blank M; Payne AS; Anhalt GJ; Avivi C; Barshack I; David M; Shoenfeld Y
    Clin Exp Immunol; 2010 Dec; 162(3):543-9. PubMed ID: 20964642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.